Search database
Filter
4439
Text search: medicines use
Featured
Language
Document type
2339
736
631
249
186
109
77
47
22
18
13
9
2
Countries
233
178
146
110
102
101
89
89
84
83
83
82
73
71
70
68
68
65
59
56
54
45
44
39
39
36
34
33
27
25
23
22
22
21
21
20
20
20
20
20
19
19
19
18
16
15
14
13
13
12
12
12
11
11
9
9
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
682
256
156
155
126
94
90
82
62
33
30
30
30
24
24
23
23
22
21
20
19
19
19
19
17
17
16
16
16
16
16
16
15
14
14
14
13
13
13
13
12
12
12
12
11
11
11
11
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1780
412
270
201
94
87
52
2
2
2
Toolboxes
359
341
276
276
270
212
133
124
105
101
94
88
87
85
75
66
44
37
19
12
12
11
7
2
 Add to my MEDBOX

WHO Model Formulary
recommended

World Health Organization WHO (2008) C_WHO
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
 Download
  View PDF
 Add to my MEDBOX

A model quality assurance system for procurement agencies

World Health Organization World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank (2007) C_WHO
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products ... more
 Add to my MEDBOX

WHO Guideline on Country Pharmaceutical Pricing Policies

World Health Organization WHO World Health Organization (2020) C_WHO
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov ... more
 Add to my MEDBOX

Fueling the Philippines’ HIV Epidemic

Human Rights Watch (2016) C1
Government Barriers to Condom Use by Men Who Have Sex With Men
 Download
  View PDF
 Add to my MEDBOX

Guidance for national strategic planning for tuberculosis

World Health Organization (2022) C_WHO
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health ... more
 Download
  View PDF
 Add to my MEDBOX

Consolidated strategic information guidelines for viral hepatitis planning and tracking progress towards elimination: guidelines

World Health Organization WHO (2019) C_WHO
The document describes the use of strategic information at various stages of the response in the context of strengthening broader health information systems. Strategic information can be defined as data collected at all service delivery and administ ... more
 Download
  View PDF
 Add to my MEDBOX

Healthy animals, Happy farmers!

Food and Agriculture Organization (FAO) (2016) C2
When an infection strikes, and medicines like antibiotics (and other antimicrobials) do not work, you can lose your entire stock of animals to disease. This also puts the health of you and your family at risk when the infection can spread between an ... more
 Download
  View PDF
 Add to my MEDBOX

Service Delivery - Chapter 6

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Accessed: 26.02.2020
 External Link
 Add to my MEDBOX

A conceptual framework for the environmental surveillance of antibiotics and antibiotic resistance

Patricia M.C. Huijbers, Carl-Fredrik Flach, D.G. Joakim Larsson Centre for Antibiotic Resistance Research (CARe), University of Gothenburg (2019) C2
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenge ... more
 Download
  View PDF
 Add to my MEDBOX

Strengthening the Health Systems Response to COVID-19 - Technical guidance #3

World Health Organization (Europe) (2020) C_WHO
Supply of essential medicines and health technologies (6 April 2020) This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on mea ... more
 Add to my MEDBOX

Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID 19. Tercera versión, 1 de febrero del 2022
recommended

Organización Mundial de la Salud OMS OPS (2022) C_WHO
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
 External Link
 Add to my MEDBOX

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC
In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide ... more
 Download
  View PDF
 Add to my MEDBOX

WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention

World Health Organization WHO (2022) C_WHO
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ... more
 Download
  View PDF
 Add to my MEDBOX

Falling short

International Union Against Tuberculosis and Lung Disease; Treatment Action Group; msh; ec al. (2017)
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.
 Download
  View PDF
 Add to my MEDBOX

Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)
recommended

World Health Organization WHO (2018) C_WHO
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be incr ... more
 External Link
 Add to my MEDBOX

WHO Model Formulary for Children
recommended

World Health Organization WHO (2010) C_WHO
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009. In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Chil ... more
 Download
  View PDF
 Add to my MEDBOX

Inter-Agency Reproductiv e Health Kits for Crisis Situations - Manual

UNFPA (2011)
A consolidated set of reproductive health kits for use by humanitarian agencies. These kits are intended to speed up the provision of appropriate reproductive health services in emergency and refugee situations.
 Add to my MEDBOX

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended

World Health Organization (2015) C_WHO
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk ... more
 Download
  View PDF
 Add to my MEDBOX

Managing possible serious bacterial infection in young infants when referral is not feasible
recommended

World Health Organization WHO (2015) C_WHO
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker ... more
 Download
  View PDF
 Add to my MEDBOX

Medicinal plants for forest conservation and health care

Bodeker, Gerard (Ed.) Food and Agriculture Organization (FAO) (1997) C1
Non-Wood Forest Products 11 Traditional medicine and its use of medicinal plants is dependent on reliable supply of plant materials. The book focuses on the interface between medicinal plant use an ... more
 Download
  View PDF
 Add to my MEDBOX

European Drug Report - Trends and Developments

European Monitoring Centre for Drugs and Drug Addiction (2018) C1
Table of contents: - Preface - Introductory note and acknowledgements - Commentary - Chapter 1: Drug supply and the market - Chapter 2: Drug use prevalence and trends - Chapter 3: Drug-related harms and responses - Annex: National data tables ... more
 Download
  View PDF
 Add to my MEDBOX

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV - Interim Guidelines

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection HIV Treatment
 Download
  View PDF
 Add to my MEDBOX

Time is running out

UN Children's Fund UNICEF (2019) CC
Technical Note on Antimicrobial Resistance This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal ... more
 Download
  View PDF
 Add to my MEDBOX

Prevention of mother-to-child transmission of hepatitis B virus: Guidelines on antiviral prophylaxis in pregnancy

World Health Organization WHO (2020) C_WHO
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
 Download
  View PDF
 Add to my MEDBOX

Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin

World Health Organization WHO (2021) C_WHO
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ... more
 Download
  View PDF
 Add to my MEDBOX

Operationalizing management of sick young infants with possible serious bacterial infection (PSBI) when referral is not feasible in the context of existing maternal, newborn, and child health programm
recommended

World Health Organization WHO (2015) C_WHO
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker ... more
 Download
  View PDF
 Add to my MEDBOX

Kenya Pharmaceutical Sector Development Strategy

United Nations Industrial Develoopment Organization (2012) C1
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
 Download
  View PDF
 Add to my MEDBOX

Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2023

UNAIDS (2022) C_WHO
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are enc ... more
 External Link
 Add to my MEDBOX

TOOLKIT: ANGINA

World Heart Federation (2023) CC
This campaign by Servier and the World Heart Federation builds on the success of the USE TO ACT NOW ON ANGINA campaign. In addition to raising awareness of the importance of acting now, this campaign explores some about the common, but less well-kno ... more
 Download
  View PDF
 Add to my MEDBOX

Third progress analysis of implementation of antimicrobial resistance national action plans in the WHO South-East Asia Region

World Health Organization WHO (2022) C_WHO
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder or impossible to treat, and increasing the risk of disease spread, ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Operational package for assessing, monitoring and evaluating country pharmaceutical situations

WHO World Health Organization (2007) C_WHO
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use stan ... more
 External Link
 Add to my MEDBOX

Code of Practice to minimize and contain Antimicrobial Resistance

Food and Agriculture Organisation of the United Nations FAO, World Health Organization WHO (2021) C_WHO
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the ... more
 Download
  View PDF
 Add to my MEDBOX

Code of Practice to minimize and contain Antimicrobial Resistance WHO and FAO

Food and Agriculture Organization of the United Nations FAO, World Health Organization WHO (2021) C_WHO
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the ... more
 Download
  View PDF
 Add to my MEDBOX

The Importance of Pharmacovigilance

World Health Organization WHO (2020) C_WHO
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic ... more
 Download
  View PDF
 Add to my MEDBOX

Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy
recommended

World Health Organization WHO (2022) C_WHO
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthi ... more
 External Link
 Add to my MEDBOX

Counterfeit drugs and medical devices in developing countries

Beverly D Glass (2014) CC
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f ... more
 Download
  View PDF
 Add to my MEDBOX

Patents and licences on antiretrovirals: A snapshot

UNITAID; WHO (2014)
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV ... more
 Download
  View PDF
 Add to my MEDBOX

A Guide For Patients, Family Members And Community Caregivers - Caregiver Booklet

World Health Organization WHO (2021) C_WHO
Accessed 21 July 2021:The Caregiver Booklet is designed to help patients,family members, and community caregivers in the home-based care of serious long term illness. Home care is best for many people with long term illnesses,including those who are close to the end of life. All patients bein ... more
 Download
  View PDF
 Add to my MEDBOX

Nepal Multiple Indicator Cluster Survey. Key Findings

Central Bureau of Statistics and UNICEF Nepal (2015) C1
MICS surveys measure key indicators that allow countries to generate data for use in policies and programmes, and to monitor progress towards the Millennium Development Goals (MDGs) and other internationally agreed upon commitments.
 Download
  View PDF
 Add to my MEDBOX

Health protection guidance in the event of a nuclear weapons explosion

World Health Organization (2003) C_WHO
Recently there have been increased concerns about the development and possible use of nuclear weapons by certain countries or by terrorists. This document provides advice to the general public on how best to act to minimize any health co ... more
 Download
  View PDF
 Add to my MEDBOX

Updating national essential medicine lists: a step-by-step advocacy guide

MSH Management Sciences for Health (MSH) (2016) C1
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on cou ... more
 Download
  View PDF
 Add to my MEDBOX

Severe Acute Malnutrition Update: Current WHO Guidelines and the WHO Essential Medicine List for Children

Williams, Phoebe CM.; Berkley, James A. (2016) C1
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i ... more
 Download
  View PDF
 Add to my MEDBOX

A Field Guide to Antibiotic Stewardship in Outpatient Settings

Telligen, Quality Innovation Network National Coordinating Center, Centers for Medicare & Medicaid Services (CMS) (2018) C2
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewa ... more
 Add to my MEDBOX

Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
recommended

World Health Organization WHO (2021) C_WHO
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of ... more
 Add to my MEDBOX

WHO good manufacturing practices for pharmaceutical products: main principles

World Health Organization WHO (2014) C_WHO
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status, ... more
 Download
  View PDF
 Add to my MEDBOX

Nature, biodiversity and health: an overview of interconnections

World Health Organization. Regional Office for Europe (2021) C_WHO
Urbanization, land use, global trade and industrialization have led to profound and negative impacts on nature, biodiversity and ecosystems across the world. The ongoing depletion of natural resources not only afects environmental conditions but als ... more
 Add to my MEDBOX

Diagnostics, medical devices & other health products catalog (GDF)

Stop TB Partnership World Health Organization WHO (2022) C_WHO
GDF is the largest global provider of quality-assured tuberculosis (TB) medicines, diagnostics, and laboratory supplies to the public sector. Since 2001, GDF has facilitated access to high-quality TB care in over 130 countries, providing treatmen ... more
 Download
  View PDF
 Add to my MEDBOX

Health needs assessment of the adult population in Ukraine: survey report September 2022

World Health Organisation WHO (2023) C_WHO
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully co ... more
 Add to my MEDBOX

Antimicrobial resistance and access to antibiotics

World Health Organization WHO EMHJ – Vol. 30 No. 12 – 2024 (2024) C_WHO
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their i ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Pharmacovigilance and Medicine Information in Rwanda (2016)

Ministry of Health, Rwanda (2016) C2
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
 External Link
 Add to my MEDBOX

Antimicrobial resistance in the WHO African region: current status and roadmap for action

Essack S.Y., A.T. Desta, R.E. Abotsi et al. Journal of Public Health (2016) C2
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in ... more
 Download
  View PDF
 Add to my MEDBOX

Harmonized monitoring and evaluation indicators for procurement and supply management systems

WHO (2011) C_WHO
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
 Download
  View PDF
 Add to my MEDBOX

Household Water Treatment and Storage

Oxfam (2008) C1
This technical brief presents the current options for safe storage and point of use water treatment. It is intended to help field staff working in a variety of locations to decide upon the most appropriate course of action for providing safe water f ... more
 Download
  View PDF
 Add to my MEDBOX

Prevention and Control of Cholera Uganda
recommended

Ministry of Health Uganda, Control of Diarrheal Diseases (2017) C1
Operational Guidelines for the national and district health workers & planners. These new approaches include use of selective chemotherapy, Rapid Diagnostic Tests (RDTs), Zinc for treatment of cholera in children and complementary ... more
 External Link
 Add to my MEDBOX

Non communicable diseases kit 2016 (NCDK)

WHO Regional Office for the Eastern Mediterranean (2017) C_WHO
WHO has developed a new health kit to support treatment for chronic disease patients in emergency settings. The prevalence of NCDs is increasing worldwide, including in emergency/crisis-prone areas. Yet current humanitarian response has not accounted for this emerging burden. The NCD kit attends to ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the production, control and regulation of snake antivenom immunoglobulins

World Health Organization (WHO) (2017) C_WHO
Replacement of Annex 2 of WHO Technical Report Series, No. 964 ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants

World Health Organization (WHO) (2003) C_WHO
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ... more
 Download
  View PDF
 Add to my MEDBOX

Positive health, dignity and prevention for women and their babies. Flipchart

Inter-Agency Task Team (IATT) (2018) C1
A treatment literacy guide for pregnant women and mothers living with HIV
Positive Health, Dignity and Prevention for Women and their Babies is intended for use by networks of women living with HIV, women’s groups, peer educators and o ... more
 Download
  View PDF
 Add to my MEDBOX

Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure

World Health Organization WHO (2018) C_WHO
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly use ... more
 Download
  View PDF
 Add to my MEDBOX

Brief psychosocial interventions

World Health Organization (2012) C_WHO
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
 Download
  View PDF
 Add to my MEDBOX

WHO mhGAP Guideline update
recommended

WHO WHO (2015) C_WHO
Update of the Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
 Download
  View PDF
 Add to my MEDBOX

Health, Rights and Drugs
recommended

UNAIDS (2019) C_WHO
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
 Download
  View PDF
 Add to my MEDBOX

Getting it right: WHO guidance to diagnose correctly 90% of people living with HIV

A. Sands World Health Organization (2015) C_WHO
8th IAS Conference on HIV Pathogenesis 19-22 July 2015 Vancouver Anita Sands Prequalification Team – Diagnostics Essential Medicines and Health Product
 External Link
 Add to my MEDBOX

Curbing Antimicrobial Resistance in Food Animal Production

Johns Hopkins Center for a Livable Future (2016) C2
Antimicrobials are widely used in food animal production, and use is rapidly increasing. In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middl ... more
 External Link
 Add to my MEDBOX

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance

C. M J E Vandenbroucke-Grauls, G. Kahlmeter, J. Kluytmans et al. BMJ Global Health (2019) C2
BMJ Global Health Vol.4 (2019 no.4 The Drug Resistance Index (DRI) is proposed as measure of antibiotic effectiveness in a given country, by combining, in a single metric the use of various antibiotic groups and the resistance proportions of severa ... more
 Add to my MEDBOX

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 6

World Health Organization (WHO) World Health Organization (WHO) (2017) C_WHO
Module 6 Pharmacists July 2017 Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharma ... more
 Download
  View PDF
 Add to my MEDBOX

Tanzania: The National Action Plan on AMR 2017-2022

The United Republic of Tanzania - Ministry of Health Community Development Gender Elderly and Children World Health Organization WHO (2017) C_WHO
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication programmes that targets human, animal and plant ... more
 Download
  View PDF
 Add to my MEDBOX

The Core Elements of Human Antibiotic Stewardship Programs in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2018) C_CDC
Antibiotic stewardship refers to coordinated efforts and activities that seek to measure and improve use of antibiotics. Implementation of ASPs has demonstrated positive public health and clinical impacts including reducing costs, lengths of hospita ... more
 Download
  View PDF
 Add to my MEDBOX

COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine

European Medicine Agency (2020) CC
23 April 2020EMA/202483/2020 Rev Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have s ... more
 Add to my MEDBOX

Interim Infection Prevention and Control Recommendations for Coronavirus Disease 2019 (COVID-19) in Health Care Settings

Ministry of Health, Kenya (2020) C2
Accessed: 02.05.2020 These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) ... more
 Add to my MEDBOX

Rapid hospital readiness checklist: Interim Guidance
recommended

World Health Organization WHO (2020) C_WHO
Updated 20 Nov. 2020 Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that req ... more
 Add to my MEDBOX

Maintaining and prioritizing HIV prevention services in the time of COVID-19

UNAIDS; GPC (2020) CC
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, one ... more
 Add to my MEDBOX

African Union and the Africa CDC’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
7 June 2021 The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonizatio ... more
 Add to my MEDBOX

Pharmacies and Drug Shops: Expanding contraceptive choice and access in the private sector

Dwyer, S.C.; et al. HIP Family Planning High Impact Practices (2021) CC
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the ... more
 Add to my MEDBOX

Extemporaneous Formulation

Abida Haq binti Syed M. Haq et al. Ministry of Health Malaysia (2015) CC
Compounding of pharmaceutical formulations remain as the core skill of pharmacists and this manual is produced to include well referenced recipes that are easy to prepare, use readily available ingredients, have the l ... more
 External Link
 Add to my MEDBOX

Antimicrobial Resistance Resource Platform
recommended

World Health Organization WHO (2022) C_WHO
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to ... more
 External Link
 Add to my MEDBOX

United against Rabies Collaboration

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children ... more
 External Link
 Add to my MEDBOX

Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030: United Against Rabies Collaboration: first annual progress report

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are childre ... more
 External Link
 Add to my MEDBOX

Case study: Developing sustainable tools to improve community engagement and enhance Neglected Tropical Diseases programme equity

Countdown - Calling time on neglected tropical diseases (2023) C2
Accessed on 31.03.2023 COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community enga ... more
 Download
  View PDF
 Add to my MEDBOX

Recommended package of interventions for HIV, viral hepatis and STI prevention, diagnosis, treatment and care for people who inject drugs: policy brief

World Health Organisation (WHO) (2023) C_WHO
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit ... more
 Add to my MEDBOX

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 1: conducting a comprehensive assessment

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will h ... more
 Download
  View PDF
 Add to my MEDBOX

Guide for Implementing the Monitoring-Training-Planning (MTP) Approach to Build Skills for Pharmaceutical Management

Rational Pharmaceutical Management Plus Program Management Sciences for Health; USAID (2009) CC
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi ... more
 Add to my MEDBOX

Antimicrobial resistance and primary health care

World Health Organization WHO (2018) C_WHO
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, anti ... more
 Download
  View PDF
 Add to my MEDBOX

The legal and regulatory framework for community pharmacies in the WHO European Region

World Health Organization WHO, Regional Office of Europe (2019) C_WHO
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com ... more
 Download
  View PDF
 Add to my MEDBOX

Global Action Plan on Antimicrobial Resistance
recommended

World Health Organization WHO (2015) C_WHO
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and acces ... more
 Download
  View PDF
 Add to my MEDBOX

Reproductive, Maternal, Neonatal and Child Health Program Overview and Pharmaceuticals Management Training for Pharmacy Professionals. Participant Manual

Ministry of Health, Federal Democratic Republic of Ethiopia (2018) CC
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of maternal and child health services. As part of these efforts, the ministry is also exerting concerted efforts to improve availability and ... more
 Add to my MEDBOX

Therapeutics and COVID-19: living guideline (Arabic)
recommended

World Health Organization WHO (2022) C_WHO
3 March 2022 The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf ... more
 Add to my MEDBOX

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

World Health Organization WHO (2007) C_WHO
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
 Add to my MEDBOX

Recommendations for management of common childhood conditions
recommended

World Health Organization (2012)
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
 Add to my MEDBOX

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu KIT (Royal Tropical Institute) Development Policy & Practice Vrije Universiteit Amsterdam (2008) CC
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
 Download
  View PDF
 Add to my MEDBOX

Safety Monitoring of medicinal products

Uppsala Monitoring Centre World Health Organization (2012) C_WHO
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the programmatic management of drug-resistant tuberculosis

World Health Organization (2011) C_WHO
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention an ... more
 Download
  View PDF
 Add to my MEDBOX

Guide Material for Medical Store Management Training
recommended

Community Development Medicinal Unit (2012) C_WHO
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of ... more
 Add to my MEDBOX

Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization (2015) C_WHO
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant ... more
 External Link
 Add to my MEDBOX

Ghana’s National Health insurance scheme and maternal and child health: a mixed methods study

Kavita Singh, Isaac Osei-Akoto, Frank Otchere et al. BMC Health Services Research (2015) C1
Ghana is attracting global attention for efforts to provide health insurance to all citizens through the National Health Insurance Scheme (NHIS). With the program’s strong emphasis on maternal and child health, an expectation of the program is that members will have increased ... more
 Add to my MEDBOX

WHO Safe Childbirth Checklist Implementation Guide
recommended

World Health Organization WHO (2015) C_WHO
This implementation guide has been developed to help birth attendants and health-care leaders successfully launch and sustain use of the WHO Safe Childbirth Checklist. Development, use and implement ... more
 Download
  View PDF
 Add to my MEDBOX

Botswana: Guidelines for stability testing of pharmaceutical products

Ministry of Health, Gabarone, Botswana (2009) C2
This guideline is intended to provide requirements to applicants wishing to submit applications for registration of medicines in Botswana.
 Download
  View PDF
 Add to my MEDBOX

Critically important antimicrobials for human medicine

World Health Organization WHO (2017) C_WHO
5th revised edition. This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, ... more
 External Link
 Add to my MEDBOX

PEDIATRIC KIT including SAM/MC Children - WHO PED/SAM 2020
recommended

World Health Organization (WHO) (2020) C_WHO
For 50 SAM children with medical complications and for a paediatric ward of 10-15 beds for 3 months The PED/SAM kit is especially designed to provide medicines, renewables and equipment suitable for children and to treat the common childhood illn ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV
recommended

World Health Organization (WHO) (2022) C_WHO
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i ... more